Enrico M Minnella

Trials

Studies that name Enrico M Minnella as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:14 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04899271 · A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

  Dompé Farmaceutici S.p.A · terminated · New-onset Type 1 Diabetes · study director
• N/A
  NCT04581005 · Prehabilitation in Esophageal Cancer Care

  McGill University Health Centre/Research Institute of the McGill University Health Centre · unknown · Esophageal Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.